Potassium Citrate Tablet, Extended Release
Product Images NDC 71335-2897

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 71335-2897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Potassium Citrate showing three potassium carboxylate groups attached to a central carbon with one hydroxyl group, along with a water molecule (H2O) indicating a hydrated form.*
FDA Label Image

Table 1. (Table 1.)

Table 1. (Table 1.)
A table titled 'Effect of Potassium Citrate In Patients With Calcium Oxalate Nephrolithiasis' showing data on stones formed per year across four patient groups. It includes columns for baseline stones, stones formed on treatment, remission percentages, and any decrease percentages, with a total row summarizing the data for all groups.*
FDA Label Image

Label (Lbl713352897)

Label (Lbl713352897)
The label for Potassium Citrate Extended-Release Tablets USP 15 mEq (1620 mg) features storage instructions, a child-resistant warning, and QR codes for dosage information. The product is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Ascent Pharmaceuticals. The package contains 100 tablets and includes the NDC 71335-2897-1 barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.